104 related articles for article (PubMed ID: 19364496)
1. p27 deregulation by Skp2 overexpression induced by the JAK2V617 mutation.
Furuhata A; Kimura A; Shide K; Shimoda K; Murakami M; Ito H; Gao S; Yoshida K; Tagawa Y; Hagiwara K; Takagi A; Kojima T; Suzuki M; Abe A; Naoe T; Murate T
Biochem Biophys Res Commun; 2009 Jun; 383(4):411-6. PubMed ID: 19364496
[TBL] [Abstract][Full Text] [Related]
2. Skp2-mediated p27(Kip1) degradation during S/G2 phase progression of adipocyte hyperplasia.
Auld CA; Fernandes KM; Morrison RF
J Cell Physiol; 2007 Apr; 211(1):101-11. PubMed ID: 17096381
[TBL] [Abstract][Full Text] [Related]
3. STAT1 represses Skp2 gene transcription to promote p27Kip1 stabilization in Ras-transformed cells.
Wang S; Raven JF; Koromilas AE
Mol Cancer Res; 2010 May; 8(5):798-805. PubMed ID: 20407011
[TBL] [Abstract][Full Text] [Related]
4. Skp2 promotes adipocyte differentiation via a p27Kip1-independent mechanism in primary mouse embryonic fibroblasts.
Okada M; Sakai T; Nakamura T; Tamamori-Adachi M; Kitajima S; Matsuki Y; Watanabe E; Hiramatsu R; Sakaue H; Kasuga M
Biochem Biophys Res Commun; 2009 Feb; 379(2):249-54. PubMed ID: 19109928
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemically detected expression of p27(Kip1) and Skp2 predicts survival in patients with intrahepatic cholangiocarcinomas.
Hashimoto N; Yachida S; Okano K; Wakabayashi H; Imaida K; Kurokohchi K; Masaki T; Kinoshita H; Tominaga M; Ajiki T; Ku Y; Okabayashi T; Hanazaki K; Hiroi M; Izumi S; Mano S; Okada S; Karasawa Y; Maeba T; Suzuki Y
Ann Surg Oncol; 2009 Feb; 16(2):395-403. PubMed ID: 19034576
[TBL] [Abstract][Full Text] [Related]
6. Skp2 inversely correlates with p27 and tuberin in transformed cells.
Rosner M; Hanneder M; Siegel N; Valli A; Fuchs C; Hengstschläger M
Amino Acids; 2009 Jul; 37(2):257-62. PubMed ID: 18604603
[TBL] [Abstract][Full Text] [Related]
7. Stat3 induces oncogenic Skp2 expression in human cervical carcinoma cells.
Huang H; Zhao W; Yang D
Biochem Biophys Res Commun; 2012 Feb; 418(1):186-90. PubMed ID: 22252296
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of the S-phase kinase-associated protein 2 in thyroid cancer.
Chiappetta G; De Marco C; Quintiero A; Califano D; Gherardi S; Malanga D; Scrima M; Montero-Conde C; Cito L; Monaco M; Motti ML; Pasquinelli R; Agosti V; Robledo M; Fusco A; Viglietto G
Endocr Relat Cancer; 2007 Jun; 14(2):405-20. PubMed ID: 17639054
[TBL] [Abstract][Full Text] [Related]
9. Oncogenic properties and prognostic implications of the ubiquitin ligase Skp2 in cancer.
Hershko DD
Cancer; 2008 Apr; 112(7):1415-24. PubMed ID: 18260093
[TBL] [Abstract][Full Text] [Related]
10. TG101209, a small molecule JAK2-selective kinase inhibitor potently inhibits myeloproliferative disorder-associated JAK2V617F and MPLW515L/K mutations.
Pardanani A; Hood J; Lasho T; Levine RL; Martin MB; Noronha G; Finke C; Mak CC; Mesa R; Zhu H; Soll R; Gilliland DG; Tefferi A
Leukemia; 2007 Aug; 21(8):1658-68. PubMed ID: 17541402
[TBL] [Abstract][Full Text] [Related]
11. Cyclin D1 induction of cellular migration requires p27(KIP1).
Li Z; Jiao X; Wang C; Ju X; Lu Y; Yuan L; Lisanti MP; Katiyar S; Pestell RG
Cancer Res; 2006 Oct; 66(20):9986-94. PubMed ID: 17047061
[TBL] [Abstract][Full Text] [Related]
12. Phosphorylation of p27Kip1 by JAK2 directly links cytokine receptor signaling to cell cycle control.
Jäkel H; Weinl C; Hengst L
Oncogene; 2011 Aug; 30(32):3502-12. PubMed ID: 21423214
[TBL] [Abstract][Full Text] [Related]
13. Growth inhibition of a tongue squamous cell carcinoma cell line (Tca8113) in vitro and in vivo via siRNA-mediated down-regulation of skp2.
Fang L; Hu Q; Hua Z; Li S; Dong W
Int J Oral Maxillofac Surg; 2008 Sep; 37(9):847-52. PubMed ID: 18620845
[TBL] [Abstract][Full Text] [Related]
14. Suppression of anoikis by SKP2 amplification and overexpression promotes metastasis of esophageal squamous cell carcinoma.
Wang XC; Wu YP; Ye B; Lin DC; Feng YB; Zhang ZQ; Xu X; Han YL; Cai Y; Dong JT; Zhan QM; Wu M; Wang MR
Mol Cancer Res; 2009 Jan; 7(1):12-22. PubMed ID: 19147533
[TBL] [Abstract][Full Text] [Related]
15. Combined inhibition of Janus kinase 1/2 for the treatment of JAK2V617F-driven neoplasms: selective effects on mutant cells and improvements in measures of disease severity.
Liu PC; Caulder E; Li J; Waeltz P; Margulis A; Wynn R; Becker-Pasha M; Li Y; Crowgey E; Hollis G; Haley P; Sparks RB; Combs AP; Rodgers JD; Burn TC; Vaddi K; Fridman JS
Clin Cancer Res; 2009 Nov; 15(22):6891-900. PubMed ID: 19887489
[TBL] [Abstract][Full Text] [Related]
16. EB1089 induces Skp2-dependent p27 accumulation, leading to cell growth inhibition and cell cycle G1 phase arrest in human hepatoma cells.
Luo W; Chen Y; Liu M; Du K; Zheng G; Cai T; Zhang W; Zhao F; Yao T; Yang R; Chen J
Cancer Invest; 2009 Jan; 27(1):29-37. PubMed ID: 19160095
[TBL] [Abstract][Full Text] [Related]
17. Activated Jak2 with the V617F point mutation promotes G1/S phase transition.
Walz C; Crowley BJ; Hudon HE; Gramlich JL; Neuberg DS; Podar K; Griffin JD; Sattler M
J Biol Chem; 2006 Jun; 281(26):18177-83. PubMed ID: 16632470
[TBL] [Abstract][Full Text] [Related]
18. In vitro differentiation of HT-29 M6 mucus-secreting colon cancer cells involves a trychostatin A and p27(KIP1)-inducible transcriptional program of gene expression.
Mayo C; Lloreta J; Real FX; Mayol X
J Cell Physiol; 2007 Jul; 212(1):42-50. PubMed ID: 17311291
[TBL] [Abstract][Full Text] [Related]
19. Novel effect of helenalin on Akt signaling and Skp2 expression in 3T3-L1 preadipocytes.
Auld CA; Hopkins RG; Fernandes KM; Morrison RF
Biochem Biophys Res Commun; 2006 Jul; 346(1):314-20. PubMed ID: 16750815
[TBL] [Abstract][Full Text] [Related]
20. A novel function of OLIG2 to suppress human glial tumor cell growth via p27Kip1 transactivation.
Tabu K; Ohnishi A; Sunden Y; Suzuki T; Tsuda M; Tanaka S; Sakai T; Nagashima K; Sawa H
J Cell Sci; 2006 Apr; 119(Pt 7):1433-41. PubMed ID: 16554441
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
